Source:http://linkedlifedata.com/resource/pubmed/id/10741565
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-5-19
|
pubmed:abstractText |
A recent case-control study suggests that the allele (AC)23 of a variable number tandem repeat (VNTR) associated to the aldose reductase (ALR2) gene could be related to early retinopathy in Type 2 diabetics. By means of a longitudinal-retrospective study, we aimed to seek for a relationship between the rate of progression of retinopathy and the (AC)23 allele of the VNTR associated to the ALR2 gene. A random sample was obtained of 27 Type 2 diabetics (aged 68.1 +/- 10.6 years, diabetes duration = 20.7 +/- 4.8 years, mean HbA1 = 10.6 +/- 1.6%). The mean HbA1 was the arithmetic average of 2.2 measurements per patient per year of total glycosilated hemoglobin (Gabbay method, normal range: 4.2-7.5%). Retinopathy was graded by an Ophthalmologist in a scale from zero to four score points. The genotype of the (AC), VNTR was determined by 32P-PCR plus sequenciation in a Perkin-Elmer laser device. The Mann-Whitney test and either chi2 or Fisher's exact test were used. A P < 0.05 was considered as statistically significant. The retinopathy progression rate (RPR, points x year(-1)) was calculated by dividing the increment of retinopathy score (delta Retinopathy Score, [points]), by the duration of the follow up [years]. The 12 diabetics having the (AC)23 allele had a mean RPR 8.9 times higher (0.40 +/- 0.61 points x year(-1)) than the 15 patients who had alleles other than (AC)23 (0.045 +/- 0.099 points x year(-1), P = 0.037). Both groups were similar with respect to: mean HbA1 (10.5 +/- 1.4 and 10.7 +/- 1.7%, P = 0.95), age at diagnosis (48.5 +/- 6.3 and 46.3 +/- 14.0 years, P = 0.81), diabetes' duration (21.3 +/- 4.7 and 20.2 +/- 4.9 years, P = 0.41) and serum creatinine (0.89 +/- 0.2 and 1.13 +/- 0.5 mg dl(-1), P = 0.35). We concluded that, in Type-2 diabetics having similar glycemic control, the (AC)23 allele of the VNTR associated to the ALR2 gene, is associated to a 8.9 times faster progression of retinopathy than in patients who have other alleles.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0168-8227
|
pubmed:author |
pubmed-author:AcostaA MAM,
pubmed-author:ArriagadaPP,
pubmed-author:ClaroJ CJC,
pubmed-author:DíazRR,
pubmed-author:EmmerichMM,
pubmed-author:FutersSS,
pubmed-author:MaizAA,
pubmed-author:MoralesPP,
pubmed-author:OlmosPP,
pubmed-author:SchiaffinoRR,
pubmed-author:SiegelSS,
pubmed-author:VeghKK,
pubmed-author:VelascoSS,
pubmed-author:VollrathVV
|
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
169-76
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10741565-Age of Onset,
pubmed-meshheading:10741565-Aged,
pubmed-meshheading:10741565-Aldehyde Reductase,
pubmed-meshheading:10741565-Base Sequence,
pubmed-meshheading:10741565-Case-Control Studies,
pubmed-meshheading:10741565-Chile,
pubmed-meshheading:10741565-Diabetes Mellitus, Type 2,
pubmed-meshheading:10741565-Diabetic Retinopathy,
pubmed-meshheading:10741565-Disease Progression,
pubmed-meshheading:10741565-Hemoglobin A, Glycosylated,
pubmed-meshheading:10741565-Humans,
pubmed-meshheading:10741565-Middle Aged,
pubmed-meshheading:10741565-Minisatellite Repeats,
pubmed-meshheading:10741565-Molecular Sequence Data,
pubmed-meshheading:10741565-Polymerase Chain Reaction,
pubmed-meshheading:10741565-Polymorphism, Genetic
|
pubmed:year |
2000
|
pubmed:articleTitle |
(AC)23 [Z-2] polymorphism of the aldose reductase gene and fast progression of retinopathy in Chilean type 2 diabetics.
|
pubmed:affiliation |
Department of Nutrition, Diabetes and Metabolism, College of Medicine, Pontificia Universidad Católica de Chile, Santiago. polmos@med.puc.cl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|